Diversified Healthcare Trust reported Q2 2026 total revenues of $365,387 (thousands), down from $382,712 (thousands) a year earlier, and a narrowed net loss of $37,419 (thousands) versus $91,639 (thousands). For the first half, revenues were $731,858 (thousands) with a net loss of $80,694 (thousands).
The Senior Housing Operating Portfolio (SHOP) generated Q2 residents fees and services of $317,921 (thousands); comparable SHOP communities saw 6.6% revenue growth and higher occupancy and rates, while total SHOP revenue declined due to asset sales. SHOP occupancy for all properties reached 82.5%, with an average monthly rate of $5,693.
The Medical Office and Life Science Portfolio produced Q2 rental income of $40,116 (thousands), with comparable occupancy of 95.8% and positive leasing spreads; weighted average rental rates on 1H 2026 leasing rose 8.1%. Consolidated Q2 net operating income increased to $84,443 (thousands) from $70,132 (thousands), helped by lower interest expense of $37,083 (thousands) versus $50,926 (thousands) after prior-year refinancings.
At June 30, 2026, total assets were $4,238,698 (thousands) and shareholders’ equity was $1,582,831 (thousands). Cash and restricted cash totaled $136,196 (thousands); there were no borrowings on the secured revolving credit facility, with $150,000 available. The company paid $0.02 per share in common distributions in 1H 2026 and declared an additional $0.01 per share for Q3.
Diversified Healthcare Trust reported second quarter 2026 results for the quarter ended June 30, 2026. Total revenues were $365,387 (dollars in thousands) versus $382,712 a year earlier. GAAP net loss narrowed to $37,419 (thousand), or $(0.16) per share. Normalized FFO rose to $38,896 (thousand), also $0.16 per share, while consolidated NOI increased to $84,443 (thousand) and Adjusted EBITDAre to $82,082 (thousand).
Performance improved notably in the senior housing operating portfolio: same property SHOP NOI grew 37.2% year over year to $51,975 (thousand), with margins at 17.3% and occupancy at 83.1%. The Medical Office and Life Science portfolio achieved same property occupancy of 95.8% and approximately 477,000 square feet of new and renewal leasing at rents 6.7% above prior levels.
Leverage metrics strengthened, with net debt to annualized Adjusted EBITDAre improving to 7.1x and interest coverage to 2.2x. As of June 30, 2026, DHC owned a $6,262,230 (thousand) healthcare real estate portfolio of 285 properties. The company declared a quarterly common distribution of $0.01 per share and reaffirmed full year 2026 guidance, including Total NOI of $307,000–$323,000 and Normalized FFO of $135,000–$150,000 (thousands) or $0.56–$0.62 per share.
BlackRock, Inc. reports beneficial ownership of 21,571,190 shares of Diversified Healthcare Trust common stock, representing 8.9% of the class as disclosed in Amendment No. 3 to its Schedule 13G filing.
BlackRock has sole voting power over 21,184,066 shares and sole dispositive power over 21,571,190 shares, with no shared voting or dispositive power. The shares are held on behalf of various clients, and no single underlying investor is reported to hold more than five percent of Diversified Healthcare Trust’s outstanding common shares.
JONES LISA HARRIS reported acquisition or exercise transactions in this Form 4 filing.
DIVERSIFIED HEALTHCARE TRUST director Lisa Harris Jones received 12,401 Common Shares of Beneficial Interest as an equity award. The shares were granted at no cash cost under the company’s equity compensation plan, bringing her direct holdings to about 170,287 shares. This total includes 392.041 shares accumulated through a dividend reinvestment plan.
SOMERS JEFFREY P. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Jeffrey P. Somers received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 under the company’s equity compensation plan. The grant was at a stated price of $0.00 per share, bringing his direct holdings to 177,079 shares.
Neher Dawn K. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Dawn K. Neher received an award of 12,401 Common Shares of Beneficial Interest as equity compensation. The shares were granted at no cash cost to her under the company’s equity compensation plan and increase her direct holdings to 78,579 shares.
Bilotto Christopher J. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust President and CEO Christopher J. Bilotto received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 at no cash cost, as part of the company’s equity compensation plan. After this grant and shares added through a dividend reinvestment plan, his direct holdings total about 279,246.802 shares, including 560.894 shares accumulated from reinvested dividends since his last ownership report.
PORTNOY ADAM D. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Adam D. Portnoy reported an equity-based compensation grant and updated holdings. He received 12,401 Common Shares of Beneficial Interest as an award under the company’s equity compensation plan, bringing his directly held stake to 427,557.55 shares.
The filing also lists 23,250,019 Common Shares of Beneficial Interest held indirectly through ABP Trust. Mr. Portnoy, as sole trustee, officer and controlling shareholder of ABP Trust, may be deemed a beneficial owner of those shares but disclaims beneficial ownership except to the extent of his pecuniary interest.
Felder Alan L. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Alan L. Felder received an award of 12,401 Common Shares of Beneficial Interest on 2026-06-10. The shares were granted at no cash cost to him pursuant to the company’s equity compensation plan.
Following this grant, Felder directly holds 75,124 common shares, as reported in the filing.
Hollis Phyllis M. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Phyllis M. Hollis received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 under the company’s equity compensation plan. The award was granted at no cash cost per share as part of her director compensation.
After this grant, she directly holds 100,147.703 common shares. This total includes 666.634 shares accumulated through a dividend reinvestment plan since her prior Section 16 filing, showing ongoing participation in the company’s reinvestment program in addition to the new equity award.